Company: MATV
Filing Date: 2025-03-21
Form Type: DEF 14A
Source: 0001140361-25-009899
Chunk: 63

Company: Mativ Holdings, Inc.
Filing Date: 2025-03-21
Form: DEF 14A
Chunk 63
---
 rate of approximately 0.80% of the Company’s outstanding shares of Common Stock. Proposed Amendment On March 19, 2025, the Board approved an amendment to the 2024 Plan, subject to approval by the Company’s stockholders, that would increase the total remaining number of shares available for issuance under the amended 2024 Plan by 2,300,000 (the “Plan Amendment”). After adding the shares of Common Stock that remained available for future issuances under the 2024 Plan as of March 21, 2025 (63,614, assuming outstanding PSUs are counted at maximum) to the additional shares approved by the Plan Amendment, there will be a total of 2,363,614 shares available for future issuance under the 2024 Plan. If the Plan Amendment is not approved by the Company’s stockholders, the Company will continue to operate the 2024 Plan pursuant to its current provisions. Equity Grant Practices Outstanding Equity Awards Please see below for additional information regarding the number of shares underlying outstanding equity awards and remaining available for future grants under the 2024 Plan:

| Total shares underlying outstanding stock options and stock appreciation rights (Appreciation Awards)(1)                                                   |     |    356,650 |
| Total shares underlying outstanding full value awards (includes restricted stock, restricted stock units and performance share units)(2)                   |     |  2,736,386 |
| Total number of shares remaining available for future grant under the 2024 Plan                                                                            |     |     63,614 |
| Total number of shares remaining available for future grant under the Outside Director Plan                                                                |     |     51,008 |
| Incremental shares requested under the 2024 Plan                                                                                                           |     |  2,300,000 |
| Total number of shares available for future grant under the 2024 Plan and Outside Director Plan upon shareholder approval of the incremental share request |     |  2,414,622 |
| Total number of shares of common stock outstanding as of March 1, 2025                                                                                     |     | 54,517,608 |

| (1) | Our Appreciation Awards outstanding as of March 21, 2025 had a weighted-average exercise price of $79.41 and a weighted-average remaining term of 2.0 years. The total number of Appreciation Awards outstanding as of March 21, 2025 includes both stock appreciation rights and stock options granted by legacy Neenah. |

| (2)